Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Stay up-to-date on everything from DCCPS LinkedIn
Spotlight
NEW VIDEO
Survivorship Research for People Living with Advanced and Metastatic Cancers
Learn more about NOT-CA-25-024: Survivorship Research for People Living with Advanced and Metastatic Cancers. In this video, Dr. Michelle Mollica and Dr. Lisa Gallicchio provide an overview of this NOSI, which highlights the National Cancer Institute’s interest in applications proposing observational or intervention studies focused on survivorship for people living with advanced and metastatic cancers.
UPCOMING PRESENTATION
April 2025 – Register now for this upcoming OCS Director’s Series webinar. On April 29, 2025, from 2-3 p.m. ET, Dr. Hung-Jui (Ray) Tan will present Testicular Cancer Survivorship: Current State and Future Opportunities.
UPCOMING PRESENTATION
OCS Director's Series Presents Waiting Rooms and Lost Days: Measuring the Time Costs of Cancer Care
May 2025 – Register now for this upcoming OCS Director’s Series webinar. On May 20, 2025, from 2-3 p.m. ET, Dr. Rachel I. Vogel and Dr. Julian Wolfson will present Waiting Rooms and Lost Days: Measuring the Time Costs of Cancer Care.
Funding Opportunities for Researchers
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Quick Links
Featured Graph and Statistic
Individuals Living with Metastatic Cancer
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.
Cancer Survivor Statistics
It is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population.